Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,416 | 335 | 99.1% |
| Education | $49.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,756 | 103 | $0 (2024) |
| Merck Sharp & Dohme LLC | $656.70 | 47 | $0 (2023) |
| PFIZER INC. | $451.47 | 24 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $402.82 | 28 | $0 (2023) |
| Novo Nordisk Inc | $325.55 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $310.61 | 21 | $0 (2021) |
| Lilly USA, LLC | $213.03 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $138.61 | 10 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $126.42 | 7 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $121.32 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $360.29 | 20 | AstraZeneca Pharmaceuticals LP ($89.86) |
| 2023 | $522.66 | 30 | AstraZeneca Pharmaceuticals LP ($231.53) |
| 2022 | $759.42 | 50 | AstraZeneca Pharmaceuticals LP ($273.05) |
| 2021 | $951.95 | 64 | AstraZeneca Pharmaceuticals LP ($219.37) |
| 2020 | $765.85 | 46 | AstraZeneca Pharmaceuticals LP ($400.15) |
| 2019 | $591.58 | 38 | AstraZeneca Pharmaceuticals LP ($208.54) |
| 2018 | $820.99 | 49 | AstraZeneca Pharmaceuticals LP ($179.21) |
| 2017 | $692.38 | 39 | AstraZeneca Pharmaceuticals LP ($154.59) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Oncology | ||||||
| 06/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Oncology | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 GraftGuide | Food and Beverage | Cash or cash equivalent | $19.30 | General |
| Category: Wound Care | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Oncology | ||||||
| 01/25/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Respiratory | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 10/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,902 | 5,471 | $330,439 | $156,743 |
| 2022 | 32 | 2,299 | 7,685 | $449,736 | $226,385 |
| 2021 | 33 | 2,495 | 8,541 | $501,311 | $249,886 |
| 2020 | 37 | 2,802 | 9,149 | $533,306 | $231,471 |
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 3 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 35 | $2,065 | $350.68 | 17.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 80 | 154 | $1,540 | $341.60 | 22.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 24 | $1,200 | $337.56 | 28.1% |
| 85610 | Blood test, clotting time | Office | 2022 | 15 | 68 | $1,292 | $287.57 | 22.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 79 | 640 | $6,400 | $241.94 | 3.8% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2022 | 13 | 37 | $740.00 | $184.78 | 25.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 53 | $530.00 | $157.44 | 29.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 140 | 1,484 | $2,968 | $132.60 | 4.5% |
| 84550 | Uric acid level, blood | Office | 2022 | 24 | 26 | $650.00 | $115.45 | 17.8% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 27 | 44 | $528.00 | $34.01 | 6.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 20 | $120.00 | $23.47 | 19.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 395 | 2,091 | $313,590 | $187,024 | 59.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 179 | 735 | $30,806 | $7,523 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 80 | 115 | $11,500 | $7,352 | 63.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 49 | $9,800 | $7,062 | 72.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 49 | 49 | $7,350 | $6,192 | 84.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 204 | 303 | $18,180 | $5,090 | 28.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 233 | 383 | $24,895 | $4,044 | 16.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 13 | 42 | $7,560 | $3,350 | 44.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 59 | 65 | $5,850 | $3,284 | 56.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 234 | 424 | $10,176 | $3,281 | 32.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 166 | 214 | $11,128 | $2,852 | 25.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 15 | $3,375 | $2,164 | 64.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 16 | $2,080 | $1,307 | 62.8% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 43 | 43 | $1,118 | $1,118 | 100.0% |
About Dr. Emmanuel Barias, MD
Dr. Emmanuel Barias, MD is a Family Medicine healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316998024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emmanuel Barias, MD has received a total of $5,465 in payments from pharmaceutical and medical device companies, with $360.29 received in 2024. These payments were reported across 336 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,416).
As a Medicare-enrolled provider, Barias has provided services to 9,498 Medicare beneficiaries, totaling 30,846 services with total Medicare billing of $864,484. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Oakhurst, NJ
- Active Since 05/15/2006
- Last Updated 03/17/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316998024
Products in Payments
- FARXIGA (Drug) $831.71
- JANUVIA (Drug) $380.13
- BREZTRI (Drug) $285.44
- SYMBICORT (Drug) $275.16
- JARDIANCE (Drug) $270.36
- ELIQUIS (Drug) $267.89
- Trintellix (Drug) $247.45
- NURTEC ODT (Drug) $224.53
- FASENRA (Biological) $168.79
- BEVESPI AEROSPHERE (Drug) $161.88
- BELSOMRA (Drug) $148.01
- TRINTELLIX (Drug) $138.13
- Tresiba (Drug) $129.06
- TROKENDI XR (Drug) $126.42
- GVOKE HYPOPEN (Drug) $121.32
- Ozempic (Drug) $110.30
- Amitiza (Drug) $91.35
- STEGLATRO (Drug) $88.30
- XARELTO (Drug) $87.61
- TRULICITY (Drug) $80.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oakhurst
Dr. David Drake, Md, MD
Family Medicine — Payments: $3,876
Joshua Hesson, Pa-C, PA-C
Family Medicine — Payments: $1,727
Daniel Schaffner, Md, MD
Family Medicine — Payments: $1,379
Ho Bui, Md, MD
Family Medicine — Payments: $190.93
Mr. Isaac Dweck, M.d, M.D
Family Medicine — Payments: $103.84
Mrs. Julie Whitfield, Fnp, FNP
Family Medicine — Payments: $83.28